Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA

Go back to Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA
Eisai Co Ltd (AMEX: ESALF) Delayed: 28.71 --0 (-0%)
Previous Close $28.71    52 Week High $66.25 
Open $28.71    52 Week Low $53.50 
Day High $28.71    P/E N/A 
Day Low $28.71    EPS $0.00 
Volume 10,600       

Eisai Co Ltd American Depositary Shares (AMEX: ESALY) Delayed: 61.51 --0 (-0%)
Previous Close $61.51    52 Week High $67.60 
Open $49.73    52 Week Low $53.55 
Day High $61.51    P/E N/A 
Day Low $61.51    EPS $0.00 
Volume 1,907,007       

Merck & Co. (NYSE: MRK) Delayed: 133.49 +3.07 (2.35%)
Previous Close $130.42    52 Week High $65.46 
Open $130.25    52 Week Low $47.97 
Day High $133.53    P/E 90.81 
Day Low $128.91    EPS $1.47 
Volume 4,325,140